Global Cochlear Implants Market Report 2024: Market Forecast for 5 Regions and 17+ Countries, Company Profiles of the Top 10+ Major Market Players
January 25, 2024 09:39 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Cochlear Implants Market" report has been added to ResearchAndMarkets.com's offering.The global cochlear implants market size was estimated to...
BLUEMOTH Introduces First-of-its-Kind Digital Prescription Hearing Technology Experience
August 02, 2023 09:00 ET
|
BLUEMOTH
SEATTLE, Aug. 02, 2023 (GLOBE NEWSWIRE) -- BLUEMOTH, a pioneer in consumer-first hearing wellness, today announced the launch of a virtual destination that gives users the freedom to discover and...
World Hearing Day: Widex Canada launches campaign to demystify tinnitus and encourage early treatment
March 02, 2023 15:30 ET
|
Widex
TORONTO, March 02, 2023 (GLOBE NEWSWIRE) -- Widex, one of the world’s leading hearing aid manufacturers, is marking World Hearing Day this week by urging Canadians to take action at the onset of...
Otonomy Announces Change in Stock Exchange Listing
December 22, 2022 07:53 ET
|
Otonomy, Inc.
SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq)...
Widex Canada survey finds Tinnitus awareness high among primary care providers, but referrals to hearing specialists lag behind
November 30, 2022 05:00 ET
|
Widex
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- A survey conducted by Widex Canada, one of the world’s leading hearing aid manufacturers, has revealed that while 58 per cent of primary healthcare...
Widex broadens hearing aid appeal with Widex SoundRelax for tinnitus management, improved relaxation and wellbeing
September 01, 2022 06:00 ET
|
Widex
TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Widex is building on the success of its revolutionary family of intelligent Widex Moment™ hearing devices to introduce Widex Moment Sheer™, a hearing aid...
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
August 01, 2022 07:30 ET
|
Otonomy, Inc.
OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue development of OTO-313 and implement other...
The U.S is projected to Dominate Tinnitus Management Market during Forecast Period Owing to Rapid Surge in Number of Geriatric Populations | Future Market Insights, Inc.
July 21, 2022 11:55 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, July 21, 2022 (GLOBE NEWSWIRE) -- In a recent market survey, Future Market Insights finds out that, the global tinnitus management market was estimated at a value of US$ 2.4 Bn in 2020...
Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
July 18, 2022 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Otonomy to Participate in the H.C. Wainwright Global Investment Conference
May 18, 2022 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...